Effect of Health Information Technologies on Cardiovascular Risk Factors among Patients with Diabetes

Purpose of Review To identify a common effect of health information technologies (HIT) on the management of cardiovascular disease (CVD) risk factors among people with type 2 diabetes (T2D) across randomized control trials (RCT). Recent Findings CVD is the most frequent cause of morbidity and mortal...

Full description

Saved in:
Bibliographic Details
Published in:Current diabetes reports 2019-06, Vol.19 (6), p.28-12, Article 28
Main Authors: Yoshida, Yilin, Boren, Suzanne A., Soares, Jesus, Popescu, Mihail, Nielson, Stephen D., Koopman, Richelle J., Kennedy, Diana R., Simoes, Eduardo J.
Format: Article
Language:English
Subjects:
Cardiovascular Diseases
Diabetes
Diabetes Mellitus, Type 2
Health risk assessment
Humans
Macrovascular Complications in Diabetes (VR Aroda and A Getaneh
Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)
Medical Informatics
Medicine
Medicine & Public Health
Risk Factors
Section Editors
Topical Collection on Macrovascular Complications in Diabetes
Triglycerides
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of Review To identify a common effect of health information technologies (HIT) on the management of cardiovascular disease (CVD) risk factors among people with type 2 diabetes (T2D) across randomized control trials (RCT). Recent Findings CVD is the most frequent cause of morbidity and mortality among patients with diabetes. HIT are effective in reducing HbA1c; however, their effect on cardiovascular risk factor management for patients with T2D has not been evaluated. Summary We identified 21 eligible studies (23 estimates) with measurement of SBP, 20 (22 estimates) of DBP, 14 (17 estimates) of HDL, 14 (17 estimates) of LDL, 15 (18 estimates) of triglycerides, and 10 (12 estimates) of weight across databases. We found significant reductions in SBP, DBP, LDL, and TG, and a significant improvement in HDL associated with HIT. As adjuvants to standard diabetic treatment, HIT can be effective tools for improving CVD risk factors among patients with T2D, especially in those whose CVD risk factors are not at goal.
ISSN:1534-4827
1539-0829
DOI:10.1007/s11892-019-1152-3